WhatDoTheyPrescribe.com is an educational resource explaining real-world prescribing patterns and is not a substitute for professional medical advice.

What do they prescribe?

Specify State (optional)

Search by Prescriber

Search by Drug

Doctors Who Prescribe Montelukast Sodium in Arkansas

Find doctors, physicians, and healthcare providers who prescribe Montelukast Sodium in Arkansas. This page lists the top prescribers of Montelukast Sodium based on Medicare Part D data, including the number of claims, patients served, and total drug costs.

What is Montelukast Sodium?

Montelukast sodium chewable tablets are a leukotriene receptor antagonist indicated for: • prevention and chronic treatment of asthma in patients 2 years of age and older ( 1.1 ). • Acute prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older ( 1.2 ). It belongs to a class of drugs known as leukotriene receptor antagonist.

Total Claims in Arkansas
120,437
1.1% of all Montelukast Sodium prescriptions nationwide
Total Beneficiaries in Arkansas
25,729
Total Cost in Arkansas
$1,746,577

Top Prescribers in AR(1+)

Specify State (optional)

PrescriberLocationTypeClaimsBeneficiariesCost
Shahla NaomanBatesville, ARPulmonary Disease1,208243$16,481
Loading more data in background...

Find Montelukast Sodium doctors in other states

AlabamaAlaskaArizonaCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming
Data Source: Prescribing data aggregated from the official CMS.gov Medicare Part D Prescribers by Provider and Drug dataset, published by the Centers for Medicare & Medicaid Services.
Data Current As Of: 2023 (most recent CMS release). Individual prescriber counts below 11 are suppressed by CMS for patient privacy.